KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,085 | +4.0% | 112,800 | +5.2% | 0.07% | +9.0% |
| Q2 2023 | $12,585 | +49.4% | 107,200 | +1.9% | 0.07% | +36.7% |
| Q1 2023 | $8,422 | +1.1% | 105,200 | 0.0% | 0.05% | -5.8% |
| Q4 2022 | $8,334 | -99.9% | 105,200 | +0.3% | 0.05% | +6.1% |
| Q3 2022 | $7,312,000 | -1.4% | 104,900 | -7.1% | 0.05% | +2.1% |
| Q2 2022 | $7,413,000 | +1.3% | 112,900 | +2.6% | 0.05% | +17.1% |
| Q1 2022 | $7,319,000 | +16.2% | 110,000 | +22.2% | 0.04% | +32.3% |
| Q4 2021 | $6,296,000 | +34.0% | 90,000 | 0.0% | 0.03% | +24.0% |
| Q3 2021 | $4,699,000 | -23.2% | 90,000 | 0.0% | 0.02% | -21.9% |
| Q2 2021 | $6,120,000 | -11.7% | 90,000 | 0.0% | 0.03% | -17.9% |
| Q1 2021 | $6,934,000 | +28.4% | 90,000 | 0.0% | 0.04% | +18.2% |
| Q4 2020 | $5,400,000 | +39.4% | 90,000 | 0.0% | 0.03% | +17.9% |
| Q3 2020 | $3,874,000 | -48.0% | 90,000 | -50.0% | 0.03% | -12.5% |
| Q2 2020 | $7,456,000 | – | 180,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |